Decision

Early access to medicines scheme (EAMS) scientific opinion: osimertinib (AZD9291) 40 and 80mg film-coated tablets

This publication was withdrawn on

The EAMS opinion for osimertinib has been withdrawn as the marketing authorisation has been adopted by the European Commission.

Information on the EAMS scientific opinion given to osimertinib (AZD9291) 40 and 80mg film-coated tablets, including the public assessment report.